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We have constructed pCL1920 and pCL1921, a pair of low copy number plasmids which contain a 580 bp BstVl fragment that carries the lac promoter/operator, multiple cloning sites and lacZ fragment of pUC19 (1) cloned in place of the poly linker region in pGB2 (2), a pSClOl derived plasmid which confers spectinomycin (50 jtg/ml) and streptomycin (100 jig/ml) resistance in Escherichia coli. All multiple cloning sites indicated are unique except for an additional EcoRI site as shown in the figure. pCL1920 and pCL1921 contain the BstVl fragment in opposite orientations with respect to the pGB2 sequences. In the absence of inducer the pCL1920/21 vectors do not produce detectable levels of/3-galactosidase in JM105 (lacP lacZAM\5) regulated low-level expression of genes inserted downstream of the lac promoter-operator when transformed into strains containing the lacP gene. They should also be useful for cloning genes which may be deleterious at high copy number. Since the pCL 1920/21 vectors are compatible with ColEl derived plasmids they can be used to form stable co-transformants together with pBR322 or pUC derived plasmids. For blue/white screening of inserts competent host cells with the lacZAMl5 gene are used, and the transformation mixture is plated on LB, spectinomycin plates pre-spread with 5 /tl of 0.2 M IPTG and 25 /tl 40 mg/ml X-gal (5-bromo-4-chloro-indolyl-/3-D-galactopyranoside) per plate. We will provide these plasmids in CL83, a recA\ recA56) derivative of JM83 (1).
